India, Aug. 9 -- Twelve of the top 40 pharmaceutical brands recorded more than 20 per cent value growth in July 2026, significantly outperforming the Indian Pharmaceutical Market (IPM), which grew 12.1 per cent during the month, according to data from Pharmarack Technologies.

Sharing insights on the market, Sheetal Sapale, Vice President - Commercial at Pharmarack Technologies, noted that the majority of the top players showed encouraging value growth during July.

Eli Lilly's Mounjaro emerged as the clear growth leader, with July sales of Rs 110 crore, registering an exceptional 157 per cent value growth. However, unit growth was negative at 43.7 per cent, indicating that the sharp value expansion was driven by factors beyond volumes. ...